ÂÜÀòÂÒÂ×

Jeremy Garris has extensive work experience in the pharmaceutical industry. Jeremy currently serves as the Vice President of Clinical Solutions at Expion Health, a position they have held since June 2022. Prior to this, Jeremy worked at Optum as the Optum Strategic Account Director for Specialty Payer Services from December 2020 to June 2022.

Before their role at Optum, Jeremy held multiple positions at OptumRx. From October 2018 to December 2020, they worked as the Director of Pharmacy Business Solutions. Prior to that, from November 2016 to October 2018, Jeremy served as the Director of Specialty Implementations/Drug List Management. In these roles, they developed strategies for new specialty drugs in the market, managed and customized a client's specialty drug list, and ensured exceptional service for new specialty members at OptumRx's specialty pharmacy, BriovaRx.

Jeremy's career also includes work at BriovaRx and Briova, where they served as the Supervisor of Pharmacy Operations from August 2015 to November 2016 and as a Clinical Pharmacist from December 2013 to August 2015, respectively. Jeremy played a crucial role in gaining members' trust and delivering high-quality care in both positions.

Additionally, Jeremy has experience as a Pharmacy Manager at Walgreens. From April 2006 to December 2013, they managed a high-volume prescription compounding store at Walgreens #9854, where they focused on providing excellent customer service and increasing prescription volume and sales. Prior to this, they held the role of Pharmacy Manager at Walgreens #5449 from August 2005 to April 2006 and at Walgreens #2538 from October 2003 to August 2005. Jeremy was recognized as a leader in prescription volume, customer service, and maintaining low sig code changes during their time at Walgreens.

Overall, Jeremy Garris has a diverse background in the pharmaceutical industry, with a focus on specialty pharmacy, strategic account management, and clinical solutions.

Jeremy Garris completed their education at two different universities. From 1995 to 2000, they attended the University of Kentucky, where they pursued a Bachelor of Science degree in Biology. Later, from 1999 to 2001, they attended the University of Rhode Island, where they obtained a Bachelor of Science degree in Pharmacy.